secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexeo Therapeutics, Inc. (LXEO)
CIK:        0001907108
Form:       8-K
Filed at:   2025-06-30T23:59:59+00:00
Accession:  0000950170-25-091671
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Lexeo stockholders elect two Class II directors, ratify KPMG as auditor
-----------------------------------------------------------------------

- Steven Altschuler, M.D. elected with 19,800,126 votes for and 2,775,771 withheld (5,374,056 broker non-votes).
- Reinaldo Diaz elected with 19,986,796 votes for and 2,589,101 withheld (5,374,056 broker non-votes).
- Ratification of KPMG LLP as independent auditor for FY2025: 27,929,327 for, 18,858 against, 1,768 abstain.
- All proposals passed; no other matters were submitted to a vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1907108/000095017025091671/0000950170-25-091671-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1907108/000095017025091671/lxeo-20250630.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-091671

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer